Scholarlink

This chapter discusses trials in which gene therapy is used to treat ornithine transcarbamylase deficiency. The studies covered include the use of gene therapy in male infants under nine years of age as well as research on mediated gene transfers.

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Ornithine Transcarbamylase Deficiency

  • 章节

  • 发表日期：

    2025年

查看全文
  • Jeffrey N. Weiss

摘要

This chapter discusses trials in which gene therapy is used to treat ornithine transcarbamylase deficiency. The studies covered include the use of gene therapy in male infants under nine years of age as well as research on mediated gene transfers.